Other Cancers Bone Metastasis Impact in mUC Patients Treated With Durvalumab ± Tremelimumab: DANUBE Study Analysis Jun 01, 2023
Other Cancers RLY-4008 Efficacy in FGFR2-Fusion Cholangiocarcinoma: ReFocus Trial Results Jun 01, 2023
Other Cancers Fixed-Dose Durvalumab Monotherapy in Previously Treated Urinary Tract Carcinoma Jun 01, 2023
Other Cancers Personalized Salvage Therapy for HL: Nivolumab Alone or in Combination With ICE Jun 01, 2023
Other Cancers Cabozantinib for Refractory Thyroid Cancer: Updated Results From COSMIC-311 Trial Jun 01, 2023
Other Cancers SANET-p Phase III Study of Surufatinib in Advanced Pancreatic Neuroendocrine Tumors Jun 01, 2023
